ArticleJournal of clinical microbiology2017
Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae.
Open access · bronzeAbstract readMulticenter StudyValidation Study
In one paragraph
Article in Journal of clinical microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 218 papers.
0numbers the graph read from it
0cells of the map it votes in
218citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
218 citing papers in PubMed, 386 citations in OpenAlex.
- Trial
- Evaluation of carbapenem inactivation method-based phenotypic assays for the detection of GES-type carbapenemases in Enterobacterales,Journal of clinical microbiology · 2026Article
- Integrating resistance biology, virulence networks, and precision therapeutics against multidrug-resistant Pseudomonas aeruginosa.Infection · 2026Review
- Carbapenemase Detection Methods in Clinical Microbiology: Conventional and Automated Approaches.Cureus · 2026Review
- Discrepancy between reference phenotypic and genotypic detection ofJournal of clinical microbiology · 2026Article
- Multidrug-resistant organism carriage in Vietnamese district hospitals before and after an antimicrobial stewardship intervention.Antimicrobial resistance and infection control · 2026Article
- National genomic surveillance reveals global plasmid and chromosomal dissemination routes of blanpj antimicrobials and resistance · 2026Article
- Evaluation of Beta-Lactamase-Producing Strains Isolated in a Tertiary Nephrology Hospital in Romania.Antibiotics (Basel, Switzerland) · 2026Article
- Difficult-to-treat resistance (DTR), treatment, and outcomes of carbapenem-resistant Enterobacterales infections in the setting of IMP-type carbapenemase predominance in Japan.Microbiology spectrum · 2026Article
- Evaluation of three variants of the carbapenem inactivation method for carbapenemase detection inJAC-antimicrobial resistance · 2026Article
- Carbapenemases: epidemiology, detection and management in a changing global landscape.JAC-antimicrobial resistance · 2026Review
- Article
- Genotypic and phenotypic evidence of extended-spectrum β-lactamase and carbapenemase-producing shigatoxigenic and intimin-producing Escherichia coli in diarrheic calves in Bangladesh: A hidden zoonotic and public health risk.Veterinary research communications · 2026Article
- Two Multidrug-ResistantPathogens (Basel, Switzerland) · 2026Article
- Detection of New Delhi metallo-β-lactamase (blaScientific reports · 2026Article
- Cefiderocol Heteroresistance in NDM-Producing Enterobacterales: A Complex Polymicrobial Infection Successfully Salvaged With Ceftazidime-Avibactam Plus Aztreonam.The American journal of case reports · 2026Article
- resaCPE: a rapid, low-cost colorimetric assay for the detection of carbapenemase-producing Enterobacterales.Journal of clinical microbiology · 2026Article
- Clinical and genomic insights into persistent carbapenem-resistant Klebsiella pneumoniae bacteremia: risk factors, resistance mechanisms, and treatment challenges.Biomedical journal · 2026Article
- Retrospective Analysis of the Epidemiology and Risk Factors for Recurrent Biliary-Source Bloodstream Infections in Oncologic Patients.Antibiotics (Basel, Switzerland) · 2026Article
- Restoration of β-lactam activity by nacubactam combinations against extensively drug-resistant K. pneumoniae harbouring diverse carbapenem resistance gene.World journal of microbiology & biotechnology · 2026Article
158 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
14 authors at 10 institutions in 1 country.
Virginia M PierceDepartment of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA vmpierce@mgh.harvard.edu.
Patricia J SimnerDepartment of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
David R LonswayDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Darcie E Roe-CarpenterBeckman Coulter Diagnostics, Inc., West Sacramento, California, USA.
J Kristie JohnsonDepartment of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
William B BrassoBD Life Sciences-Diagnostic Systems, Sparks, Maryland, USA.
April M BobenchikDepartment of Pathology and Laboratory Medicine, Lifespan Academic Medical Center, Providence, Rhode Island, USA.
Zabrina C LockettBeckman Coulter Diagnostics, Inc., West Sacramento, California, USA.
Angella Charnot-KatsikasDepartment of Pathology, University of Chicago Medical Center, Chicago, Illinois, USA.
Mary Jane FerraroDepartment of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Richard B ThomsonDepartment of Pathology, NorthShore University HealthSystem, Evanston, Illinois, USA.
Stephen G JenkinsDepartment of Pathology and Laboratory Medicine, Weill-Cornell Medical College, New York, New York, USA.
Brandi M LimbagoDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Sanchita DasDepartment of Pathology, NorthShore University HealthSystem, Evanston, Illinois, USA.
Beckman Coulter Foundation · USCenters for Disease Control and Prevention · USMassachusetts General Hospital · USNorthShore University HealthSystem · USBD Biosciences (United States) · USCornell University · USJohns Hopkins University · USProvidence College · USUniversity of Chicago Medical Center · USUniversity of Maryland, Baltimore · US
Funding
Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2MNCATS NIH HHS UL1 TR001102
Abstract
The ability of clinical microbiology laboratories to reliably detect carbapenemase-producing carbapenem-resistant
Indexed as
Bacterial Proteinsbeta-LactamasesCarbapenemsEnterobacteriaceaeHumansHydrolysisMicrobial Sensitivity TestsReproducibility of ResultsSensitivity and SpecificityBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsantimicrobial susceptibility testingbacterial antibiotic resistancebacteriological techniquescarbapenemasecarbapenemsEnterobacteriaceae
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.